We are Healthcare Mittelhessen

Education, research, economy: The intensive networking in the health sector and medicine
makes the location Central Hessen special throughout Germany.

Corona News

Innovations versus Corona

The strength of the healthcare hotspot in the heart of Germany is particularly evident in the corona crisis: many strands of national and global events are converging in Central Hessen these days. We provide an overview of the most exciting projects.

> Learn more

The Data Science working group of Uni Marburg is developing a new biomedical database: CORDITE for future research and drug production.
Read more
For more than three decades Werner Seeger has been researching sudden lung failure caused by viruses. In this interview, Seeger talks about the coronavirus situation at the UKGM, as well as promising studies and what he thinks about political decisions made during this pandemic.
Read more

Latest Stories

Prof. Dr. Joybrato Mukherjee, the President of the Justus Liebig University Giessen, speaks about top-level research and scientific excellence in science as well as current challenges in medicine.
Read more
Prof. Dr. Harald Renz is medical director of the University Hospital Marburg. As a laboratory physician, he knows exactly how important individualized clinical diagnostics are.
Read more
Prof. Dr. Ralph Schermuly vom Deutschen Zentrum für Lungenforschung am Fachbereich Medizin der Justus-Liebig-Universität Gießen
Prof. Dr. Ralph Schermuly is an expert in the field of experimental pathophysiology and pulmonary hypertension. Since 2011 he and his team have been conducting research on causes and disease mechanisms to better understand pulmonary hypertension.
Read more
At the Center for Unknown and Rare Diseases (ZusE) at Marburg University Hospital, patients find help from Prof. Juergen Schaefer.
Read more
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.
Read more
In the search for medicines to treat COVID-19, lung researchers from Giessen are testing an existing active ingredient that has already been proven to prevent lung damage.
Read more